Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,956 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Retrospective study of the efficacy and safety of neoadjuvant docetaxel, carboplatin, trastuzumab/pertuzumab (TCH-P) in nonmetastatic HER2-positive breast cancer.
Tiwari SR, Mishra P, Raska P, Calhoun B, Abraham J, Moore H, Budd GT, Fanning A, Valente S, Stewart R, Grobmyer SR, Montero AJ. Tiwari SR, et al. Among authors: abraham j. Breast Cancer Res Treat. 2016 Jul;158(1):189-193. doi: 10.1007/s10549-016-3866-0. Epub 2016 Jun 20. Breast Cancer Res Treat. 2016. PMID: 27324504
Phase II randomized clinical trial evaluating neoadjuvant chemotherapy regimens with weekly paclitaxel or eribulin followed by doxorubicin and cyclophosphamide in women with locally advanced HER2-negative breast cancer: NSABP Foundation Study FB-9.
Abraham J, Robidoux A, Tan AR, Limentani S, Sturtz K, Shalaby I, Alcorn H, Buyse ME, Wolmark N, Jacobs SA. Abraham J, et al. Breast Cancer Res Treat. 2015 Jul;152(2):399-405. doi: 10.1007/s10549-015-3466-4. Epub 2015 Jul 1. Breast Cancer Res Treat. 2015. PMID: 26126970 Clinical Trial.
Neratinib, A Novel HER2-Targeted Tyrosine Kinase Inhibitor.
Tiwari SR, Mishra P, Abraham J. Tiwari SR, et al. Among authors: abraham j. Clin Breast Cancer. 2016 Oct;16(5):344-348. doi: 10.1016/j.clbc.2016.05.016. Epub 2016 May 29. Clin Breast Cancer. 2016. PMID: 27405796 Review.
Putting Breast Cancer Patients First.
Grobmyer SR, Abraham J. Grobmyer SR, et al. Among authors: abraham j. Breast J. 2017 Mar;23(2):125-126. doi: 10.1111/tbj.12704. Breast J. 2017. PMID: 28299889 No abstract available.
Endocrine therapy and related issues in hormone receptor-positive early breast cancer: a roundtable discussion by the breast cancer therapy expert group (BCTEG).
Abraham J, Caldera H, Coleman R, Elias A, Goetz MP, Kittaneh M, Lower E, Mahtani R, Terry Mamounas E, Pegram M, Rugo H, Schwartzberg L, Traina T, Vogel C. Abraham J, et al. Breast Cancer Res Treat. 2018 May;169(1):1-7. doi: 10.1007/s10549-018-4662-9. Epub 2018 Jan 19. Breast Cancer Res Treat. 2018. PMID: 29352368 Free PMC article. Review.
1,956 results